FGA139, a Novel Cysteine Protease Inhibitor, Exhibits Anti-Inflammatory and Neuroprotective Activity and Reveals Microglial Modulation via Multi-Omics Profiling
Ania Canseco-Rodríguez, Florenci V. González, Ana María Sánchez‐Pérez
This paper identifies FGA139 as a novel cysteine protease inhibitor with anti-inflammatory and neuroprotective effects, showing it modulates microglial activation through multi-omics profiling.